Met Life Investment Management, LLC Adaptive Biotechnologies Corp Transaction History
Met Life Investment Management, LLC
- $18 Billion
- Q4 2024
A detailed history of Met Life Investment Management, LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Met Life Investment Management, LLC holds 68,976 shares of ADPT stock, worth $521,458. This represents 0.0% of its overall portfolio holdings.
Number of Shares
68,976
Previous 65,326
5.59%
Holding current value
$521,458
Previous $334,000
23.65%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding ADPT
# of Institutions
224Shares Held
146MCall Options Held
19.6KPut Options Held
27.2K-
Viking Global Investors LP30MShares$227 Million0.61% of portfolio
-
Rubric Capital Management LP New York, NY14.6MShares$110 Million1.45% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$88.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.7MShares$81 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl9.42MShares$71.2 Million0.49% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $1.08B
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...